Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Tislelizumab
Trade Name
Synonyms BGB-A317
Drug Descriptions

Tislelizumab (BGB-A317) is a human monoclonal antibody that targets PD-1 (PDCD1), thereby blocking the binding of PD-L1 (CD274) and potentially resulting in activation of a T-cell immune response against tumor cells (PMID: 32769013, PMID: 32561638, PMID: 32540858).

DrugClasses Immune Checkpoint Inhibitor 146 PD-L1/PD-1 antibody 112
CAS Registry Number 1858168-59-8
NCIT ID C121775

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Allocetra-OTS + Tislelizumab Allocetra-OTS Tislelizumab 0 1
APL-1202 + Tislelizumab APL-1202 Tislelizumab 0 1
Bevacizumab + Capecitabine + LBL-007 + Tislelizumab Bevacizumab Capecitabine LBL-007 Tislelizumab 0 1
Bevacizumab + Fluorouracil + LBL-007 + Tislelizumab Bevacizumab Fluorouracil LBL-007 Tislelizumab 0 1
BGB-10188 + Tislelizumab BGB-10188 Tislelizumab 0 1
BGB-15025 + Tislelizumab BGB-15025 Tislelizumab 0 1
BGB-26808 + Tislelizumab BGB-26808 Tislelizumab 0 1
BGB-30813 + Tislelizumab BGB-30813 Tislelizumab 0 1
BGB-A3055 + Tislelizumab BGB-A3055 Tislelizumab 0 1
BGB-A425 + LBL-007 + Tislelizumab BGB-A425 LBL-007 Tislelizumab 0 1
BGB-A425 + Tislelizumab BGB-A425 Tislelizumab 0 2
BGB-A445 + Carboplatin + Tislelizumab BGB-A445 Carboplatin Tislelizumab 0 0
BGB-A445 + Cisplatin + Tislelizumab BGB-A445 Cisplatin Tislelizumab 0 0
BGB-A445 + Nab-paclitaxel + Tislelizumab BGB-A445 Nab-paclitaxel Tislelizumab 0 0
BGB-A445 + Paclitaxel + Tislelizumab BGB-A445 Paclitaxel Tislelizumab 0 0
BGB-A445 + Pemetrexed Disodium + Tislelizumab BGB-A445 Pemetrexed Disodium Tislelizumab 0 0
BGB-A445 + Tislelizumab BGB-A445 Tislelizumab 0 2
BGB-B167 + Tislelizumab BGB-B167 Tislelizumab 0 1
BGBA1217 + Capecitabine + Oxaliplatin + Tislelizumab BGBA1217 Capecitabine Oxaliplatin Tislelizumab 0 1
BGBA1217 + Capecitabine + Tislelizumab BGBA1217 Capecitabine Tislelizumab 0 1
BGBA1217 + Carboplatin + Etoposide + Tislelizumab BGBA1217 Carboplatin Etoposide Tislelizumab 0 1
BGBA1217 + Carboplatin + Nab-paclitaxel + Tislelizumab BGBA1217 Carboplatin Nab-paclitaxel Tislelizumab 0 1
BGBA1217 + Carboplatin + Paclitaxel + Tislelizumab BGBA1217 Carboplatin Paclitaxel Tislelizumab 0 1
BGBA1217 + Carboplatin + Pemetrexed Disodium + Tislelizumab BGBA1217 Carboplatin Pemetrexed Disodium Tislelizumab 0 1
BGBA1217 + Cisplatin + Etoposide + Tislelizumab BGBA1217 Cisplatin Etoposide Tislelizumab 0 1
BGBA1217 + Cisplatin + Fluorouracil + Tislelizumab BGBA1217 Cisplatin Fluorouracil Tislelizumab 0 1
BGBA1217 + Cisplatin + Paclitaxel + Tislelizumab BGBA1217 Cisplatin Paclitaxel Tislelizumab 0 1
BGBA1217 + Cisplatin + Pemetrexed Disodium + Tislelizumab BGBA1217 Cisplatin Pemetrexed Disodium Tislelizumab 0 1
BGBA1217 + Tislelizumab BGBA1217 Tislelizumab 0 6
Camrelizumab + Tislelizumab + Trastuzumab Camrelizumab Tislelizumab Trastuzumab 0 0
Canakinumab + Gemcitabine + Nab-paclitaxel + Tislelizumab Canakinumab Gemcitabine Nab-paclitaxel Tislelizumab 0 1
Capecitabine + DKN-01 + Oxaliplatin + Tislelizumab Capecitabine DKN-01 Oxaliplatin Tislelizumab 0 1
Capecitabine + Oxaliplatin + Tislelizumab Capecitabine Oxaliplatin Tislelizumab 0 1
Capecitabine + Oxaliplatin + Tislelizumab + ZW25 Capecitabine Oxaliplatin Tislelizumab ZW25 0 1
Capecitabine + Tislelizumab Capecitabine Tislelizumab 0 1
Carboplatin + Etoposide + lutetium Lu 177 dotatate + Tislelizumab Carboplatin Etoposide Tislelizumab lutetium Lu 177 dotatate 0 1
Carboplatin + Etoposide + Tislelizumab Carboplatin Etoposide Tislelizumab 0 0
Carboplatin + Gemcitabine + Tislelizumab Carboplatin Gemcitabine Tislelizumab 0 0
Carboplatin + LBL-007 + Tislelizumab Carboplatin LBL-007 Tislelizumab 0 0
Carboplatin + Nab-paclitaxel + Tislelizumab Carboplatin Nab-paclitaxel Tislelizumab 0 0
Carboplatin + Paclitaxel + Tislelizumab Carboplatin Paclitaxel Tislelizumab 0 2
Carboplatin + Pemetrexed Disodium + Tislelizumab Carboplatin Pemetrexed Disodium Tislelizumab 0 0
Cisplatin + Etoposide + Tislelizumab Cisplatin Etoposide Tislelizumab 0 1
Cisplatin + Fluorouracil + Tislelizumab Cisplatin Fluorouracil Tislelizumab 0 1
Cisplatin + Fluorouracil + Tislelizumab + ZW25 Cisplatin Fluorouracil Tislelizumab ZW25 0 1
Cisplatin + Gemcitabine + Tislelizumab Cisplatin Gemcitabine Tislelizumab 0 1
Cisplatin + LBL-007 + Tislelizumab Cisplatin LBL-007 Tislelizumab 0 0
Cisplatin + Paclitaxel + Tislelizumab Cisplatin Paclitaxel Tislelizumab 0 0
Cisplatin + Pemetrexed Disodium + Tislelizumab Cisplatin Pemetrexed Disodium Tislelizumab 0 0
Dacarbazine + Doxorubicin + Tislelizumab + Vinblastine Dacarbazine Doxorubicin Tislelizumab Vinblastine 0 1
DKN-01 + Tislelizumab DKN-01 Tislelizumab 0 1
Docetaxel + Tislelizumab Docetaxel Tislelizumab 0 1
Fluorouracil + Hydroxyurea + Pamiparib + Tislelizumab Fluorouracil Hydroxyurea Pamiparib Tislelizumab 0 1
Fruquintinib + Tislelizumab Fruquintinib Tislelizumab 0 1
Garivulimab + Tislelizumab Garivulimab Tislelizumab 0 0
HFB200301 + Tislelizumab HFB200301 Tislelizumab 0 1
HFB200603 + Tislelizumab HFB200603 Tislelizumab 0 1
HRO761 + Tislelizumab HRO761 Tislelizumab 0 1
JDQ443 + Tislelizumab JDQ443 Tislelizumab 0 1
JDQ443 + Tislelizumab + TNO155 JDQ443 TNO155 Tislelizumab 0 1
KFA115 + Tislelizumab KFA115 Tislelizumab 0 1
LBL-007 + Paclitaxel + Tislelizumab LBL-007 Paclitaxel Tislelizumab 0 0
LBL-007 + Tislelizumab LBL-007 Tislelizumab 0 2
Niraparib + Tislelizumab Niraparib Tislelizumab 0 0
Pamiparib + Tislelizumab Pamiparib Tislelizumab 0 3
Pemetrexed Disodium + Tislelizumab Pemetrexed Disodium Tislelizumab 0 1
Sitravatinib + Tislelizumab Sitravatinib Tislelizumab 0 2
Surufatinib + Tislelizumab Surufatinib Tislelizumab 0 1
SX-682 + Tislelizumab SX-682 Tislelizumab 0 1
TetMYB + Tislelizumab TetMYB Tislelizumab 0 1
Tislelizumab Tislelizumab 0 23


Additional content available in CKB BOOST